Enovis Announces First Quarter 2024 Results • Strong start to the year with sales growth of 27% on a reported basis and strong adjusted margin expansion • Reported first-quarter net loss from continuing operations of $1.32 per share with adjusted earnings per diluted share of$0.50 WILMINGTON, DE, May 2, 2024 (GLOBE NEWSWIRE)—Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the first quarter ended March 29, 2024. The Company ...